other material
confidence high
sentiment neutral
materiality 0.25
Series B Preferred holders convert ~609K shares of common stock, aggregate stated value $913K
MANGOCEUTICALS, INC.
- On March 25, 2025: 116 shares (stated value $127,600) converted to 85,067 common shares.
- Same day: 350 shares ($385,000) to 256,667 common; 146 shares ($160,600) to 107,067 common.
- On March 26, 2025: 218 shares ($239,800) converted to 159,867 common shares.
- All conversions at $1.50 per share; no commissions paid, exempt under Section 3(a)(9).